Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
Abstract
We detected large numbers of HLA-DR-positive reactive microglia (macrophages), along with Lewy bodies and free melanin, in the substantia nigra of all cases studied with Parkinson's disease (5) and parkinsonism with dementia (PD) (5). We found similar, but less extensive, pathology in the substantia nigra of six of nine cases of dementia of the Alzheimer type (DAT) but in only one of 11 age-matched nonneurologic cases. All dementia cases with a premortem diagnosis of DAT or PD showed large numbers of HLA-DR-positive reactive microglia and significant plaque and tangle counts in the hippocampus, as well as reduced cortical choline acetyltransferase activity. One of 11 nondemented controls showed mild evidence of similar cortical pathology. These data indicate that HLA-DR-positive reactive microglia are a sensitive index of neuropathologic activity. They suggest a frequent coexistence of DAT- and Parkinson-type pathology in elderly patients.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Copyright
© 1988 by AAN Enterprises, Inc.
Publication History
Published online: August 1, 1988
Published in print: August 1988
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Anti-Inflammatory Effects of Dipeptidyl Peptidase-4 Inhibitors and Their Therapeutic Application for Parkinson's Disease, Drug Targets and Therapeutics, 3, 1, (83-93), (2024).https://doi.org/10.58502/DTT.24.0030
- Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson’s Disease Risk, Molecules, 29, 7, (1470), (2024).https://doi.org/10.3390/molecules29071470
- Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes, International Journal of Molecular Sciences, 25, 16, (8838), (2024).https://doi.org/10.3390/ijms25168838
- Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats, International Journal of Molecular Sciences, 25, 14, (7790), (2024).https://doi.org/10.3390/ijms25147790
- A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease, International Journal of Molecular Sciences, 25, 12, (6525), (2024).https://doi.org/10.3390/ijms25126525
- Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease, International Journal of Molecular Sciences, 25, 8, (4330), (2024).https://doi.org/10.3390/ijms25084330
- Intranasal Administration of GRP78 Protein (HSPA5) Confers Neuroprotection in a Lactacystin-Induced Rat Model of Parkinson’s Disease, International Journal of Molecular Sciences, 25, 7, (3951), (2024).https://doi.org/10.3390/ijms25073951
- Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research, International Journal of Molecular Sciences, 25, 6, (3148), (2024).https://doi.org/10.3390/ijms25063148
- Parkinson’s Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain, International Journal of Molecular Sciences, 25, 2, (1182), (2024).https://doi.org/10.3390/ijms25021182
- Chronic Cocaine Use and Parkinson’s Disease: An Interpretative Model, International Journal of Environmental Research and Public Health, 21, 8, (1105), (2024).https://doi.org/10.3390/ijerph21081105
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.